Brayton Purcell LLP

Call For A Free Consultation
800-598-0314

Call For A Free Consultation 800-598-0314

Brayton Purcell LLP
  • Home
  • Firm Overview
    • Our Beliefs
      • Giving Back
      • Our Associations And Memberships
      • The Right To Trial By Jury
    • Regions Served
    • Careers
    • Our Employees Pets
    • Press Releases
  • Attorneys
  • Practice Areas
    • Mesothelioma/Asbestos
    • Personal Injury/Wrongful Death
    • Toxic Substances
    • Estate Planning
    • Other Areas Of Practice
  • Court Successes
    • Trial Verdicts
    • Appeals
  • Testimonials
  • Blog
  • Videos
  • Contact
  • Home
  • Firm Overview
    • Our Beliefs
      • Giving Back
      • Our Associations And Memberships
      • The Right To Trial By Jury
    • Regions Served
    • Careers
    • Our Employees Pets
    • Press Releases
  • Attorneys
  • Practice Areas
    • Mesothelioma/Asbestos
    • Personal Injury/Wrongful Death
    • Toxic Substances
    • Estate Planning
    • Other Areas Of Practice
  • Court Successes
    • Trial Verdicts
    • Appeals
  • Testimonials
  • Blog
  • Videos
  • Contact

Biomarkers May Provide Hope for Early Detection of Mesothelioma

On behalf of Brayton Purcell LLP | Jan 8, 2013 | Mesothelioma

Early cancer detection is a very important strategy for effective treatment. The earlier a cancer is found, the greater the treatment options. Often with cancer that is discovered late, treatment options are limited and the cancer is so widespread that effectiveness of any treatment is diminished.

This is true of mesothelioma, which is difficult to detect and typically has a very long latency period. It is also difficult to detect before it has become advanced in its development, making it complicated to treat and leaving its victims with short life expectancies.

Research has found that cancer cells produce biomarkers that can be used to identify the disease. The challenge with using natural biomarkers is that the body produces very small amounts of the biomarkers, and detecting them can be difficult.

The team at MIT realized that if they could amplify the biomarkers, it could allow them to identify the cancer at a much earlier stage of development.

They developed nanoparticles that can interact with cancer proteins to produce thousands of biomarkers, which then allows a urine test to uncover the disease.

Another advantage of the engineered nanoparticles is that they can be designed to identify specific cancers.

The research is still at an early stage but given their success with detecting colorectal cancer in mice, there is optimism that eventually a biomarker test can be devised for finding asbestos-related cancers like mesothelioma early enough that treatment could help patients with better quality of life and greater life expectancy.

A California mesothelioma lawyer can help those diagnosed with the disease file claims for compensation.

Source: Asbestos.com, “MIT Researchers Using New Technology that Could Make Cancer Detection Much Easier,” Tim Povtak, January 4, 2013

Recent Posts

  • Who is Most at Risk of Mesothelioma?
  • Boiler Room Workers and Asbestos Exposure
  • Mitigating the financial impact of mesothelioma treatments
  • The EPA’s difficulty with data disclosure
  • Judge orders EPA to close loopholes on asbestos-related reporting

Archives

Categories

RSS Feed

Subscribe To This Blog’s Feed

Free Consultation

Take The First Step In Resolving Your Issue. Send Us An Email.

Email Us For A Response

San Francisco
Bay Area Office

222 Rush Landing Road Novato, CA 94945

Novato Office
222 Rush Landing Road
Novato, CA 94945
Toll Free: 800-598-0314
Phone: 415-898-1555
Fax: 415-898-1247

Map & Directions

Southern California
Office

12 28th Street Venice, California 90291

Los Angeles Office
12 28th Street
Venice, California 90291
Toll Free: 800-598-0314
Phone: 415-898-1555
Fax: 415-898-1247

Map & Directions
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow

© 2021 Brayton Purcell LLP. All Rights Reserved.

Disclaimer | Site Map | Privacy Policy | Business Development Solutions by FindLaw, part of Thomson Reuters

Review Us